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Background: Rapidly growing mycobacteria (RGM) are envi-
ronmental organisms that can cause post-operative wound
infections. Infections typically occur after laparoscopic surgery
due to inadequate sterilization of heat-sensitive instruments.
We describe the clinical presentation and management of post-
operative RGM infections at Christian Medical College (CMC), a
large tertiary referral hospital in South India.
Methods&Materials: Laboratory records from1st January2012
to 31st August 2015 were examined to identify patients with cul-
turepositivepost-operativeRGMinfections. Theelectronicmedical
recordsof thesepatientswere reviewed togetherwith their haema-
tological, histological and radiographic data.
Results: Over this period, 32 patients were diagnosed with
culture proven RGM infection as a consequence of surgery.
Mycobacterium fortuitum was the commonest isolate (46.9%), fol-
lowed by M. abscessus (31.2%) and M. chelonae (18.8%). Most
patients hadwound infections (96.9%); 78.1% extended into under-
lying muscle and 28.1% into structures deep to muscle. 37.5%
patients had infection associated with prosthetic material includ-
ing surgical mesh, pacemakers, cardiac valve and a neurosurgical
shunt. Surprisingly,most patients (65.6%) had undergone open sur-
gical rather than laparoscopic procedure (25%).
Only 4 patients (12.5%) acquired RGM infection following
surgery at CMC. Over this period, 96,713 operations were per-
formed resulting in an infection rate of 0.004%. 87.5% patients
underwent operation at a different hospital, presenting to CMC
a median 4 months after operation. 43.8% received inappropriate
treatment for wound infection before presenting to CMC. 37.5%
received antibiotics and 9.4% empirical antitubercular therapy,
highlighting poor knowledge about RGM infections.
All patients were treated with surgical debridement; 75%
received subsequent antibiotics consisting of a two or three
drug combination of amikacin, levoﬂoxacin/moxiﬂoxacin, clar-
ithromycin or linezolid. Patients jointly managed by surgeons and
infectious disease physicians had a higher rate of clinical response
(75%) with less loss to follow up (25%) than those managed exclu-
sively by surgeons (43.8% and 57.25% respectively).
Conclusion: RGM infections continue to complicate routine
operations in India, although theyare a rare complicationof surgery
in our hospital. They are under-recognised and frequentlymisdiag-
nosed resulting in delays in appropriate treatment. Higher clinical
response rates are seen where management involves surgeons and
infectious disease clinicianswith laboratory support frommicrobi-
ologists.
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Background: Though IGRA has been compared to tuberculin
skin test, there is scarce clinical data in India regarding correlation
of IGRA for diagnosis of active or latent tuberculosis. The role of
IGRA for diagnosis of latent tuberculosis and initiation of prophy-
laxis in an endemic country has often been questioned.
Methods & Materials: All adult patients (age >18 years) for
whom an IGRA test was done as part of their clinical work up in our
center, in 2013 were included. Demographic and clinical details
including underlying diagnosis, indications, laboratory investiga-
tions (Mycobacterial smears, cultures and XpertMTb/rif), initiation
of prophylaxis or development of tuberculosis within 1 year of
follow up were recorded.
Results: A total of 434 patients were included, the majority
were males (61%) and the mean age was 39.4 years. The common
indications for ordering IGRA was to rule out active tuberculosis
in 329/434(75.8%) and for diagnosis of latent tuberculosis prior
to initiation of immunosuppressive therapy in 68(15.7%). IGRA
was negative in the majority of the patients (63.6%). Among the
IGRA positive 158/434(36.4%) only 4 were initiated on prophy-
laxis for possible latent tuberculosis whereas in the IGRA negative
none received prophylaxis. In the IGRA positive 50(32%) and in
the IGRA negative 47(17.6%) received empirical antituberculosis
therapy for suspected tuberculosis. M. tuberculosis was however
conﬁrmed by cultures and/or PCR in 14(3.2%) of which 8 were ini-
tially IGRA positive and 6 were IGRA negative. In the sub group
where IGRA was used to diagnose latent tuberculosis- 42/53(79%)
in the IGRA negative and 14/15(93%) among the IGRA positivewere
on immunosuppressive drugs. Of these though 15 patients were
IGRA positive, only 2 (13.3%) initiated prophylaxis possibly due to
high level of Isoniazid monoresistance in our hospital.
Conclusion: A majority of the patients were found to be IGRA
negative, which was a surprising ﬁnding in a high tuberculosis
burden country. IGRA is still being used as a supporting tool for
a diagnosis of active tuberculosis in the absence of other conﬁrma-
torymicrobiological evidence. Even if IGRA is used to rule out latent
tuberculosis there is a reluctance to initiate prophylaxis.
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